出典:Wikipedia
出典:『Wikipedia』 (2011/04/01 16:51 UTC 版)
AlloMap molecular expression testing, developed and commercialized by XDx, is a gene expression profiling test to identify heart transplant recipients with a low probability of one type of transplant rejection. The test is performed on a blood sample, providing a non-invasive test to help manage the care of patients post transplant. Prior to the availability of this test, the primary method for managing heart transplant rejection was the invasive technique of endomyocardial biopsy.